BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2009
View Archived Issues
Histamine H3 receptor modulators for treating obesity developed at Roche
Read More
Argenta and AstraZeneca jointly impart novel muscarinic M3 receptor antagonists
Read More
New cathepsin K inhibitors developed at AstraZeneca
Read More
Roche divulges antipsychotic tachykinin NK3 receptor antagonists
Read More
Novel protein kinase inhibitors manufactured at Abbott
Read More
Helsinn acquires Sapphire Therapeutics
Read More
Synvista Therapeutics terminates alagebrium and SYI-2074 trials
Read More
Gilead Sciences: Q4 overview
Read More
Connexin43 mimetic peptide shows promise in spinal cord contusion injury model
Read More
Agents interfering with Wnt pathway responses identified
Read More
Cannasat to commence phase Ib CAT-310 study for neuropathic pain
Read More
Soliris receives marketing approval in Canada for patients with PNH
Read More
International Stem Cell Corp. begins preclinical human corneal epithelial cell trial
Read More
Patient recruitment completed in Biofrontera's phase III BF-200 ALA study
Read More
FDA approves gastric ulcer incidence as primary endpoint in Pozen's clinical programs
Read More
FDA accepts as complete Eurand's response to June 2008 approvable letter for EUR-1008
Read More
Biothera expands second arm of clinical trial of Imprime PGG and Erbitux in mCRC
Read More
Roche to initiate cash tender offer for all outstanding publicly held shares of Genentech
Read More
Acrux ceases development of Fentanyl MDTS for chronic pain
Read More
Alexza to focus resources on Staccato loxapine for acute agitation
Read More
Isotechnika provides update on its lead product voclosporin
Read More
Lipoxen reports interim results for long-acting erythropoietin candidate
Read More
Merrion collaborates with Novo Nordisk on GLP-1 receptor agonist development
Read More
TheraGenetics acquired by Avacta Group
Read More
Zavesca receives E.U. approval for treatment in Niemann-Pick type C disease
Read More